Can you provide a prescription (sig) for insulin lispro (Humalog) 4 units before each meal with a sliding scale that adds 1 unit when capillary glucose is >130 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prescription Sig for Humalog Sliding Scale with Meal Dosing

Inject 4 units subcutaneously before breakfast, lunch, and dinner (within 15 minutes before or immediately after starting each meal), PLUS check blood glucose before each meal and add 1 unit for every blood glucose reading >130 mg/dL. 1

Prescription Format

Humalog (insulin lispro) 100 units/mL

Sig: Inject 4 units subcutaneously before each meal (breakfast, lunch, dinner). Check blood glucose before each injection. If blood glucose >130 mg/dL, add 1 unit to the 4-unit base dose. Inject within 15 minutes before or immediately after starting meal. Rotate injection sites (abdomen, buttocks, upper arms, upper thighs). Use a new needle for each injection.

Dispense: 2 vials (10 mL each) or equivalent pen devices
Refills: As appropriate


Critical Prescribing Details

Timing Requirements

  • Humalog must be administered within 15 minutes before or right after eating a meal 1. This is a rapid-acting insulin with onset that requires meal coordination to prevent hypoglycemia.

Injection Technique

  • Use subcutaneous injection only in stomach area, buttocks, upper legs, or upper arms 1
  • Rotate injection sites with each dose to prevent lipodystrophy (pits or thickened skin) 1
  • Never reuse needles - always use a new needle for each injection to prevent infections and blocked needles 1

Important Safety Considerations

This sliding scale approach has significant limitations you should understand:

  • Research shows sliding scale insulin alone achieves target glycemic control in only 6-12% of hospitalized patients, with 51-68% remaining poorly controlled 2
  • The approach is most appropriate only for patients with mild hyperglycemia (admission glucose <180 mg/dL), where 83-86% achieve target control 3
  • If blood glucose remains persistently >250 mg/dL, this regimen will likely fail and basal insulin should be added 3

Monitoring Requirements

  • Check blood glucose before each meal
  • Prescribe glucagon for emergency hypoglycemia - patients on prandial insulin are at risk for severe hypoglycemia 1
  • Watch for hypoglycemia symptoms: dizziness, sweating, confusion, shakiness, fast heartbeat 1

When This Regimen Fails

Current guidelines recommend against sliding scale monotherapy for most patients 4. The 2025 ADA Standards recommend:

  • Starting prandial insulin at 4 units per meal OR 10% of basal insulin dose 4
  • Increasing by 1-2 units or 10-15% if A1C remains above goal 4
  • For hypoglycemia, reduce dose by 10-20% 4

If this patient requires ongoing insulin therapy beyond acute illness, transition to a basal-bolus regimen with long-acting basal insulin plus mealtime rapid-acting insulin, as this provides superior glycemic control compared to sliding scale alone 4.

Common Pitfalls to Avoid

  • Do not mix Humalog with other insulins in the same syringe when using pens 1
  • Do not inject into areas with pits, lumps, thickened skin, or scars 1
  • Do not use if insulin appears cloudy, thick, or colored 1
  • Avoid alcohol consumption while on insulin therapy 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.